PRKAA2 and diabetic cardiomyopathy: For example, adiponectin preferentially activates AMPKα2 in cardiomyocytes via AdipoR1-mediated signaling, contributing to its cardioprotective effects in ischemic injury and diabetic cardiomyopathy (21).